Shu-o Wu Yang
Direktor/Vorstandsmitglied bei Acepodia Biotechnologies, Ltd.
Ursprung des Netzwerks ersten Grades von Shu-o Wu Yang
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
Acepodia Biotechnologies, Ltd.
 Acepodia Biotechnologies, Ltd. BiotechnologyHealth Technology Acepodia Biotechnologies, Ltd. engages in the development of cell therapies to treat patients with cancers. Its business information includes biotechnology service industry, intellectual property rights, and wholesale and retail trade of chemical raw materials. The company was founded by Patrick Yang, and by Sonny Hsiao on June 19, 2017 and is headquartered in Taipei, Taiwan.
5
| Holding Company | Biotechnology | 5 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Shu-o Wu Yang
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Corporate Officer/Principal Corporate Officer/Principal | |
| IBM | Packaged Software | Corporate Officer/Principal | |
| MERCK & CO., INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| CODEXIS, INC. | Chemicals: Specialty | Director/Board Member Director/Board Member | |
| FIVE PRIME THERAPEUTICS, INC. | Biotechnology | Director of Finance/CFO | |
IntegenX, Inc.
 IntegenX, Inc. BiotechnologyHealth Technology IntegenX, Inc. develops rapid human DNA identification technology, next-gen sequencing library preparation, and DNA/RNA ambient temperature stability and storage products. The firm platforms are the result of the integration of advanced fluidics, optics, and biochemistry capabilities to produce products for DNA-based human identity testing and forensics and biodefense applications. The company was founded by Stevan Jovanovich, Dennis W. Harris, Richard A. Mathies in 2003 and is headquartered in Pleasanton, CA. | Biotechnology | Chief Operating Officer | |
| TBG DIAGNOSTICS LIMITED | Pharmaceuticals: Major | Director/Board Member | |
The Ohio State University
 The Ohio State University Other Consumer ServicesConsumer Services Global Factory, Inc. provides collaborative manufacturing execution systems. The firm's software gather, organize & analyze demand, production & quality data from various sources and monitor key indicators & execute business processes to control, manage & optimize distributed manufacturing operations. The company was founded in 1999 and is headquartered in Santa Clara, CA. | College/University | Doctorate Degree | |
| National Chiao Tung University | College/University | Undergraduate Degree | |
| National Taiwan University | College/University | Graduate Degree Undergraduate Degree | |
TaiGen Biotechnology Co., Ltd.
 TaiGen Biotechnology Co., Ltd. Pharmaceuticals: MajorHealth Technology TaiGen Biotechnology Co., Ltd. is a research-based and product-driven pharmaceutical company engaging in the development of therapeutics for infectious diseases, cancer, and diabetes-related complications. Its activities include drug discovery, development, global regulatory, and commercialization in China. The company was founded by Ming-Chu Hsu in 2001 and is headquartered in Taipei, Taiwan. | Pharmaceuticals: Major | Director/Board Member | |
YFY Biotech Management Co
 YFY Biotech Management Co Investment ManagersFinance YFY Biotech Management Co. Ltd. (YFYBM) is a private equity investment firm located in Taipei, Taiwan. Established in 2003, they are subsidiary of the Yuen Foong Yu Group Co. Ltd., founded in 1926 with their core business initially focused on paper manufacturing. YFYBM is the investment manager of biotechnology private equity fund | Investment Managers | Chief Executive Officer | |
Polaris Pharmaceuticals, Inc.
 Polaris Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology Polaris Pharmaceuticals, Inc. researches and develops protein drugs for cancer treatment. It offers ADI-PEG 20, a biotherapeutic agent that is in advanced clinical development for the treatment of hepatocellular carcinoma and metastatic melanoma; Uricase-PEG 20; TNF-PEG 20 and CK2 inhibitor. Polaris Pharmaceuticals was founded in 2006 and is headquartered in San Diego, CA. | Medical Specialties | Director/Board Member | |
| TAIGEN BIOPHARMACEUTICALS HOLDINGS LIMITED | Biotechnology | Director/Board Member | |
| MYCENAX BIOTECH INC. | Biotechnology | Director/Board Member | |
| PHARMIGENE, INC. | Pharmaceuticals: Generic | Director/Board Member | |
| TAIWAN LIPOSOME COMPANY, LTD. | Pharmaceuticals: Major | Director/Board Member | |
Neurelis, Inc.
 Neurelis, Inc. Pharmaceuticals: MajorHealth Technology Neurelis, Inc. operates as a specialty pharmaceutical company. It is organized to license, develop and commercialize product candidates for the treatment of central nervous system disorders with a focus on the acute treatment of epilepsy and anxiety episodes. The company was founded by Craig C. Chambliss and David F. Hale in 2007 and is headquartered in San Diego, CA. | Pharmaceuticals: Major | Director/Board Member | |
NeuroSky, Inc.
 NeuroSky, Inc. SemiconductorsElectronic Technology NeuroSky, Inc. develops biosensor technology services. Its biosensors, biometric algorithms, reference designs, and big data analytics enable leading-edge innovation in mhealth products and services for measuring body and mind performance. The company was founded by Hyung Koo Lee and Jong Jin Lim in 2004 and is headquartered in San Jose, CA. | Semiconductors | Director/Board Member | |
| Taiwan Genome Sciences, Inc. | Director/Board Member | ||
| TAIMED BIOLOGICS INC. | Biotechnology | Director/Board Member | |
| National Yang Ming University | College/University | Undergraduate Degree | |
Taiwan Global BioFund
 Taiwan Global BioFund Investment ManagersFinance Taiwan Global BioFund invests exclusively in life science companies located in Taiwan and US. The fund targets companies operating in the fields of biotechnology, pharmaceuticals, diagnostics, medical devices, medical services, and medical informatics. It provides financing for seed, early and later stage capital requirements. | Investment Managers | Director/Board Member | |
| Harvard T.H. Chan School of Public Health | College/University | Graduate Degree | |
| National Health Insurance /Taiwan/ | Chief Executive Officer | ||
| TWI BIOTECHNOLOGY, INC. | Pharmaceuticals: Major | Director/Board Member | |
| TOT BIOPHARM INTERNATIONAL COMPANY LIMITED | Pharmaceuticals: Major | Director/Board Member | |
MiCareo Taiwan Co., Ltd.
 MiCareo Taiwan Co., Ltd. BiotechnologyHealth Technology MiCareo Taiwan Co., Ltd. provides tools for the analysis of rare cells. | Biotechnology | Chairman | |
MiCareo, Inc.
 MiCareo, Inc. BiotechnologyHealth Technology MiCareo, Inc. provides tools for the analysis of rare cells. It circulates tumor cell platform does rare cell isolation and analysis for cancer prognosis, treatment development, and efficacy evaluation. The firm’s product MiSelect starts with whole blood labeled with any fluorescent cell surface antibody or cocktail of multiple antibodies. The company was founded by Perry Schiro and Daniel T. Chiu in 2011 and is headquartered in Taipei, Taiwan. | Biotechnology | Director/Board Member | |
| SUNNY PHARMTECH INC. | Medical/Nursing Services | Director/Board Member | |
| SOMNICS, INC. | Electronic Equipment/Instruments | Director/Board Member | |
| MEDEON BIODESIGN, INC. | Electronic Equipment/Instruments | Director/Board Member | |
| IXENSOR CO., LTD. | Medical Specialties | Director/Board Member | |
| SYNEURX INTERNATIONAL (TAIWAN) CORP. | Biotechnology | Director/Board Member | |
| AP BIOSCIENCES INC | Biotechnology | Director/Board Member | |
| Medeon Biosurgical, Inc. | Director/Board Member | ||
| Sunny Pharma Holding Ltd. | Director/Board Member | ||
| Medeon International, Inc. | Director/Board Member | ||
| FORMOSA PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member | |
| EUSOL BIOTECH CO.,LTD. | Biotechnology | Chief Executive Officer | |
| MONTEREY INNOVATION ACQUISITION CORP. | Financial Conglomerates | Corporate Officer/Principal | |
| IO BIOTECH, INC. | Biotechnology | Director/Board Member | |
| Aspen Sciences LLC | Director/Board Member | ||
| ACEPODIA, INC. | Biotechnology | Founder Director/Board Member Founder | |
| Taiwan Pharmaceutical Manufactureres Association | President | ||
| EXCELSIOR BIOPHARMA INC. | Pharmaceuticals: Major | Director/Board Member |
Statistik
International
| Taiwan | 28 |
| Vereinigte Staaten | 18 |
| Hong Kong | 3 |
| Australien | 2 |
| Dänemark | 2 |
Sektoral
| Health Technology | 29 |
| Consumer Services | 6 |
| Finance | 4 |
| Electronic Technology | 4 |
| Technology Services | 2 |
Operativ
| Director/Board Member | 50 |
| Independent Dir/Board Member | 10 |
| Corporate Officer/Principal | 10 |
| Chairman | 8 |
| Chief Executive Officer | 8 |
Am stärksten vernetzte Beziehungen
| Insiders | |
|---|---|
| Hong Jen Chang | 34 |
| Patrick Yang | 28 |
| David Smith | 17 |
| Sonny Hsiao | 6 |
| Hsiu Yuan Li | 1 |
- Börse
- Insiders
- Shu-o Wu Yang
- Unternehmensverbindungen
